Buscar
Mostrando ítems 1-10 de 364
Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal
(ENDOCRINE SOC, 2000)
We studied the effect on bone mass of alendronate treatment for 5 yr and its withdrawal. Four hundred and forty-seven postmenopausal women with normal bone mass entered a 3-yr randomized trial followed by a 2-yr open label ...
Potentiometric determination of alendronate in pharmaceutical formulations
(Instytut Chemii Fizycznej Pan, 2004-01-01)
A simple, precise, fast and low-cost potentiometric method for alendronate determination in pharmaceutical formulations has been proposed. Alendronate present in tablets at the known concentration was potentiometrically ...
Potentiometric determination of alendronate in pharmaceutical formulations
(Instytut Chemii Fizycznej Pan, 2004-01-01)
A simple, precise, fast and low-cost potentiometric method for alendronate determination in pharmaceutical formulations has been proposed. Alendronate present in tablets at the known concentration was potentiometrically ...
Potentiometric determination of alendronate in pharmaceutical formulations
(2004-12-01)
A simple, precise, fast and low-cost potentiometric method for alendronate determination in pharmaceutical formulations has been proposed. Alendronate present in tablets at the known concentration was potentiometrically ...
Potentiometric determination of alendronate in pharmaceutical formulations
(Instytut Chemii Fizycznej Pan, 2014)
Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres
(MDPI, 2016)
In this work we synthesized mesoporous bioactive glass nanospheres (nMBG) with the aim to utilize them as substrates for loading one of the most potent amino-bisphosphonates, alendronate (AL). The results of the chemical ...
The study of sodium alendronate and the association of sodium alendronate and hydroxyapatite in the bone repair.
(Int Amer Assoc Dental Researchi, 2003-12-01)
The study of sodium alendronate and the association of sodium alendronate and hydroxyapatite in the bone repair.
(Int Amer Assoc Dental Researchi, 2003-12-01)
Ten years' experience with alendronate for osteoporosis in postmenopausal women
(MASSACHUSETTS MEDICAL SOC, 2004)
Background: Antiresorptive agents are widely used to treat osteoporosis. We report the results of a multinational randomized, double-blind study, in which postmenopausal women with osteoporosis were treated with alendronate ...
Alendronate therapy in cyclosporine-induced alveolar bone loss in rats
(Blackwell Publishing, 2007-10-01)
Background and Objective: Cyclosporine A is an immunosuppressive drug that is widely used in organ transplant patients as well as to treat a number of autoimmune conditions. Bone loss is reported as a significant side-effect ...